Valuation: Vivos Inc.

Market Cap 22.37M 19.99M 18.65M 16.94M 31.9M 2.16B 32.14M 224M 87.54M 1.1B 83.97M 82.16M 3.54B P/E 2024
-16.2x
P/E 2025 -10.2x
Enterprise Value 20.92M 18.7M 17.44M 15.84M 29.84M 2.02B 30.06M 210M 81.89M 1.03B 78.55M 76.85M 3.31B EV / Sales 2024
1,724x
EV / Sales 2025 438x
Free-Float
95.44%
Yield 2024 *
-
Yield 2025 -
1 day-3.75%
1 week+21.90%
Current month+18.00%
1 month+17.06%
3 months-31.24%
6 months-30.51%
Current year-14.37%
1 week 0.04
Extreme 0.0391
0.06
1 month 0.04
Extreme 0.0391
0.06
Current year 0.04
Extreme 0.0391
0.12
1 year 0.04
Extreme 0.0391
0.12
3 years 0.04
Extreme 0.0391
0.26
5 years 0.04
Extreme 0.0391
0.26
10 years 0.01
Extreme 0.0065
8
Manager TitleAgeSince
Chief Executive Officer 79 2016-12-13
President 44 2025-09-14
Director of Finance/CFO 59 2018-11-30
Director TitleAgeSince
Chairman 81 2016-12-13
Director/Board Member 79 2017-08-01
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Buy

Chief Executive Officer

200,000 0.0405%
9/16/26 Buy

Chairperson

25,550 0.0052%
8/10/26 Buy

Chief Executive Officer

150,000 0.0304%
Change 5-day change 1-year change 3-year change Capi.($)
-3.75%+21.90%-33.63%-11.14% 22.37M
+0.83%-1.92%+22.79%+33.44% 243B
+1.34%-1.38%+4.66%+0.05% 152B
+2.41%+1.94%-5.99%+40.76% 143B
-1.45%-4.74%-56.64%-20.65% 61.14B
-0.81%-0.63%+11.81%+17.67% 49.85B
-0.14%-1.87%+22.03%+51.95% 47.74B
+1.29%-0.23%-20.20%-18.72% 47.74B
-0.35%-1.03%-7.75%+32.53% 45.9B
-2.11%-2.16%+176.95%+94.32% 41.3B
Average -0.30%-1.06%+11.40%+22.02% 83.1B
Weighted average by Cap. +0.55%-1.28%+11.49%+24.73%

Financials

2024 2025
Net sales 28K 25.01K 23.34K 21.2K 39.92K 2.71M 40.22K 280K 110K 1.38M 105K 103K 4.43M 68.38K 61.1K 57K 51.78K 97.51K 6.61M 98.24K 685K 268K 3.36M 257K 251K 10.81M
Net income -2.91M -2.6M -2.43M -2.2M -4.15M -282M -4.18M -29.16M -11.39M -143M -10.93M -10.69M -460M -3.07M -2.74M -2.56M -2.32M -4.37M -297M -4.4M -30.71M -12M -151M -11.51M -11.26M -485M
Net Debt -2.21M -1.98M -1.84M -1.68M -3.16M -214M -3.18M -22.16M -8.66M -109M -8.31M -8.13M -350M -1.44M -1.29M -1.2M -1.09M -2.06M -140M -2.07M -14.47M -5.65M -71.05M -5.42M -5.3M -228M
Projected Income Statement - Annual - Vivos Inc.
Logo Vivos Inc.
Vivos Inc. is a radiation oncology medical device company. The Company has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.
Employees
1
Date Price Change Volume
26-10-06 US$0.0453 +5.01% 1,488,686
26-10-05 US$0.0431 -5.90% 5,359,135
26-10-02 US$0.0458 -8.05% 663,531
26-10-01 US$0.0498 -0.38% 970,617
26-09-30 US$0.0500 +3.31% 696,372
  1. Stock Market
  2. Stocks
  3. RDGL Stock